Literature DB >> 7527502

Effects of cibenzoline, a new class Ia antiarrhythmic drug, on various membrane ionic currents and action potentials of guinea-pig ventricular cells.

T Sato1, B Wu, T Kiyosue, M Arita.   

Abstract

We examined the effects of cibenzoline, a new class Ia antiarrhythmic drug, on various membrane ionic currents and action potentials of guinea-pig single ventricular cells, using patch clamp techniques in whole-cell configuration. Action potentials and the membrane currents were evoked at a clamping rate of 0.2 Hz, and all experiments were performed at 32-33 degrees C. 1) Cibenzoline (5, 10 and 30 microM) decreased the Na+ current (INa), in a concentration-dependent manner. The concentration of the half-maximal inhibition (Kd) for INa was estimated to be 7.8 microM. 2) In addition to the inhibition of INa, this drug (5, 10, and 30 microM) decreased, in a concentration-dependent manner, all other membrane currents examined, such as L-type Ca2+ current (ICa), delayed rectifier K+ current (IK), and inward rectifier K+ current (IK1). The Kd (apparent dissociation constant) values were 14.4 microM for ICa, 23.0 microM for IK, and 33.7 microM for IK1 respectively. 3) Cibenzoline (5, 10, and 30 microns) significantly shortened the action potential duration measured at both 30% and 90% repolarization without altering the resting membrane potential. From these findings, we conclude that apart from potent inhibitory effects on INa, cibenzoline possesses multiple blocking effects on other currents, e.g., ICa, IK and IK1, with a different potency (INa > ICa > IK > IK1) and with essentially the same efficacy. These effects may explain, at least in part, the alleged, potent antiarrhythmic effects of this drug.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527502     DOI: 10.1007/bf00241092

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Ionic mechanisms of action potential prolongation at low temperature in guinea-pig ventricular myocytes.

Authors:  T Kiyosue; M Arita; H Muramatsu; A J Spindler; D Noble
Journal:  J Physiol       Date:  1993-08       Impact factor: 5.182

2.  Maximal upstroke velocity as an index of available sodium conductance. Comparison of maximal upstroke velocity and voltage clamp measurements of sodium current in rabbit Purkinje fibers.

Authors:  C J Cohen; B P Bean; R W Tsien
Journal:  Circ Res       Date:  1984-06       Impact factor: 17.367

3.  Spontaneously active cells isolated from the sino-atrial and atrio-ventricular nodes of the rabbit heart.

Authors:  J Taniguchi; S Kokubun; A Noma; H Irisawa
Journal:  Jpn J Physiol       Date:  1981

4.  Cibenzoline for treatment of ventricular arrhythmias: a double-blind placebo-controlled study.

Authors:  J B Kostis; S Krieger; A Moreyra; N Cosgrove
Journal:  J Am Coll Cardiol       Date:  1984-08       Impact factor: 24.094

5.  Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.

Authors:  J S Millar; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

6.  Cibenzoline plasma concentration and antiarrhythmic effect.

Authors:  R K Brazzell; K Aogaichi; J J Heger; J C Somberg; N H Carliner; J Morganroth
Journal:  Clin Pharmacol Ther       Date:  1984-03       Impact factor: 6.875

7.  Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline.

Authors:  M Canal; B Flouvat; D Tremblay; A Dufour
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Inhibition of the myocardial Ca2+ inward current by the class 1 antiarrhythmic agent, cibenzoline.

Authors:  M Holck; W Osterrieder
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

9.  Effects of trimetazidine on action potentials and membrane currents of guinea-pig ventricular myocytes.

Authors:  T Kiyosue; S Nakamura; M Arita
Journal:  J Mol Cell Cardiol       Date:  1986-12       Impact factor: 5.000

10.  Cardiac effects of cibenzoline.

Authors:  K H Dangman
Journal:  J Cardiovasc Pharmacol       Date:  1984 Mar-Apr       Impact factor: 3.105

View more
  1 in total

Review 1.  KV11.1, NaV1.5, and CaV1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity.

Authors:  Magdalena Kowalska; Jacek Nowaczyk; Alicja Nowaczyk
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.